2019-21313. Bulk Manufacturer of Controlled Substances Registration; Siemens Healthcare Diagnostics, Inc.

ACTION:

Notice of registration.

SUMMARY:

The registrants listed below have applied for and been granted a registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of various classes of schedule I and II controlled substances.

SUPPLEMENTARY INFORMATION:

The companies listed below applied to be registered as a bulk manufacturer of a basic class of schedule I and II controlled substances. Information on previously published notices is listed below. No comments or objections were submitted for the notice.

Company	FR Docket	Published
Siegfried USA, LLC	84 FR 7129	March 1, 2019.
Patheon Pharmaceuticals, Inc	84 FR 8114	March 6, 2019.
S & B Pharma Inc	84 FR 8116	March 6, 2019.
Siemens Healthcare Diagnostics, Inc	84 FR 10534	March 21, 2019.
Synthcon, LLC	84 FR 13962	April 8, 2019.

The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of these registrants to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each of the company's compliance with state and local laws, and reviewing each company's background and history.

Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed companies.

Dated: September 23, 2019.

Thomas W. Prevoznik,

Acting Assistant Administrator, Deputy Assistant Administrator.